RKIP inhibits gastric cancer cell survival and invasion by regulating the expression of HMGA2 and OPN

Aurora-A signaling is activated in advanced stage of squamous cell carcinoma of head and neck cancer and requires osteopontin to stimulate invasive behavior

(2015) Chih-Yen Chien et al.   Oncotarget

Structural basis for RKIP binding with its substrate Raf1 kinase

(2014) Zhihua Wu et al.   BIOTECHNOLOGY LETTERS

Targeted Strategies in the Treatment of Primary Gastric Lymphomas: From Rituximab to Recent Insights into Potential New Drugs

(2014) Francesca Merchionne et al.   CURRENT MEDICINAL CHEMISTRY

At the Bench: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer

(2014) D. M. Hardbower et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Association of osteopontin with osteoarthritis

(2014) Chao Cheng et al.   RHEUMATOLOGY INTERNATIONAL

let-7 Enhances Osteogenesis and Bone Formation While Repressing Adipogenesis of Human Stromal/Mesenchymal Stem Cells by Regulating HMGA2

(2014) Jianfeng Wei et al.   STEM CELLS AND DEVELOPMENT

Effects of HMGA2 on malignant degree, invasion, metastasis, proliferation and cellular morphology of ovarian cancer cells

(2014) Yan-Ni Xi et al.   Asian Pacific Journal of Tropical Medicine

IMP3 RNP Safe Houses Prevent miRNA-Directed HMGA2 mRNA Decay in Cancer and Development

(2014) Lars Jønson et al.   Cell Reports

Role of Osteopontin in Modulation of Hydroxyapatite Formation

(2013) Graeme K. Hunter   CALCIFIED TISSUE INTERNATIONAL

Osteopontin: Versatile modulator of liver diseases

(2013) Sumiko Nagoshi   HEPATOLOGY RESEARCH

RKIP: Much more than Raf Kinase inhibitory protein

(2013) Fahd Al-Mulla et al.   JOURNAL OF CELLULAR PHYSIOLOGY

HMGA2 and high-grade serous ovarian carcinoma

(2013) Jingjing Wu et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Clinical effects of Helicobacter pylori outside the stomach

(2013) Francesco Franceschi et al.   Nature Reviews Gastroenterology & Hepatology

RKIP and HMGA2 regulate breast tumor survival and metastasis through lysyl oxidase and syndecan-2

(2013) M Sun et al.   ONCOGENE

Raf kinase inhibitor protein (RKIP) in cancer

(2012) June Escara-Wilke et al.   CANCER AND METASTASIS REVIEWS

Human osteopontin splicing isoforms: Known roles, potential clinical applications and activated signaling pathways

(2012) E.R. Gimba et al.   CANCER LETTERS

Identification of novel metastasis suppressor signaling pathways for breast cancer

(2012) Andy J. Minn et al.   CELL CYCLE

Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance

(2011) Yun-Fan Sun et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Metastasis suppressors in human benign prostate, intraepithelial neoplasia, and invasive cancer: their prospects as therapeutic agents

(2011) Zahraa I. Khamis et al.   MEDICINAL RESEARCH REVIEWS

PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection

(2010) Yong-Feng Xu et al.   JOURNAL OF HEPATOLOGY

HMGA2: A pituitary tumour subtype-specific oncogene?

(2010) Monica Fedele et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

HMGA2 Maintains Oncogenic RAS-Induced Epithelial-Mesenchymal Transition in Human Pancreatic Cancer Cells

(2009) Sugiko Watanabe et al.   AMERICAN JOURNAL OF PATHOLOGY

Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7

(2009) Surabhi Dangi-Garimella et al.   EMBO JOURNAL

Effects of Raf Kinase Inhibitor Protein Expression on Metastasis and Progression of Human Breast Cancer

(2009) H. Z. Li et al.   MOLECULAR CANCER RESEARCH

Raf kinase inhibitory protein (RKIP): A physiological regulator and future therapeutic target

(2008) Lingchun Zeng et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability

(2008) F Al-Mulla et al.   JOURNAL OF CLINICAL PATHOLOGY